Allentown, a leading provider of life science solutions has acquired ClorDiSys to further expand Allentown's footprint in the global biomedical research and life science markets.
Charles Simmons, CEO of Allentown stated,...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose...
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announces that the...
Cyclo Therapeutics, Inc, a clinical stage biotechnology company focused on developing transformative therapies for rare and neurological diseases with limited treatment options, and Applied Molecular...
